Tradestie Institutional Equity Comparison Engine

LENS vs OPHC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

OPHC Overall Edge

OPHC Captures Institutional Edge (3โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to OptimumBank Holdings, Inc. (OPHC) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, LENS trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus OPHC at 5.6x Forward P/E and 50.5% operating margin (+51.2% YoY). In options structure, LENS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OPHC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner OPHC
LENS N/M vs OPHC 5.6x Fwd P/E
Growth & Margin Winner OPHC
Op Margin N/A vs 50.5% ยท YoY N/A vs +51.2%
Momentum & Technical Winner OPHC
1Y +4.2% vs +93.5% ยท 52W Pos 15% vs 60%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
LENS Cboe BZX
Sarmaya Thematic ETF
Institutional Equity
$36.59
-3.17% 1D
Market Cap N/A
1M Return -14.33%
1Y Return +4.22%
Forward P/E N/M
Unified AI Score
38.3 / 100 SELL
Tech 24.0 Fund 37.0 Flow 50.0 Mom 45.0
OPHC NYSE American
OptimumBank Holdings, Inc.
National Commercial Banks
$8.03
-1.83% 1D
Market Cap $127.4M
1M Return -9.16%
1Y Return +93.49%
Forward P/E 5.6x
Unified AI Score
40.4 / 100 SELL
Tech 16.0 Fund 43.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: LENS +4.22% OPHC +93.49% Spread: +89.27 pp (OPHC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
LENS TTM Op. Margin: N/A OPHC TTM Op. Margin: 50.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on LENS vs OPHC. Trailing 12-month operating profitability (LENS N/A vs OPHC 50.5%) and valuation multiples (LENS N/M vs OPHC 5.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: LENS (1) vs OPHC (9)
Institutional Metric LENS OPHC Criterion Row Winner
Market Capitalization Scale N/A $127.4M Larger Scale OPHC
Trailing P/E Ratio Valuation N/M 8.2x Lower Multiple OPHC
Forward P/E Ratio Valuation N/M 5.6x Lower Multiple OPHC
Revenue Growth (YoY) Growth N/A +51.2% Higher Growth OPHC
Operating Margin (TTM) Profitability N/A 50.5% Higher Margin OPHC
Net Profit Margin Profitability N/A 37.0% Higher Margin OPHC
Return on Equity (ROE) Capital Efficiency N/A 17.5% Higher ROE OPHC
52-Week Range Position Momentum 15% ($34โ€“$51) 60% ($4โ€“$11) Stronger Trend OPHC
Beta / 30D Volatility Risk Regime 0.79ฮฒ ยท 22% Vol 0.60ฮฒ ยท 36% Vol Lower Realized Risk LENS
Unified Institutional Score Composite Signal 38.3 / 100 (SELL) 40.4 / 100 (SELL) Higher Composite OPHC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full LENS vs OPHC Buy Guide
LENS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LENS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OPHC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OPHC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither LENS nor OPHC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.